-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Tonix Pharmaceuticals Holding Corp. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q2 2024 to Q4 2024.
- Tonix Pharmaceuticals Holding Corp. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending December 31, 2024 was $3.68M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)